Tobias Moser

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 31

Top Topics

Cerebrospinal Fluid

Multiple Sclerosis

Top Venues

Annals of clinical and translational neurology

International journal of molecular sciences

European journal of neurology

Epileptic disorders : international epilepsy journal with videotape

This page only lists publications with an associated author ORCID identifier.

Publications

Tobias Moser, Eugen Trinka
Epilepsy surgery in multiple sclerosis. Epileptic disorders : international epilepsy journal with videotape 26 (2) (2024)
Ferdinand Otto, Michael Seiberl, Lara Bieler, Tobias Moser, Waltraud Kleindienst, Walter Wallner-Essl, Peter Koelblinger, Peter Wipfler, Andrea Harrer
Beyond T cell toxicity - Intrathecal chemokine CXCL13 indicating B cell involvement in immune-related adverse events following checkpoint inhibition: A two-case series and literature review. European journal of neurology 31 (7) (2024)
Tobias Moser, Fabian Foettinger, Wolfgang Hitzl, Bianka Novotna, Thomas Berger, Gabriel Bsteh, Franziska Di Pauli, Harald Hegen, Barbara Kornek, Dieter Langenscheidt, Johann Sellner
Alemtuzumab treatment for multiple sclerosis in Austria: An observational long-term outcome study. Annals of clinical and translational neurology 11 (6) (2024)
Julia Feige, Tobias Moser, Katja Akgün, Kerstin Schwenker, Wolfgang Hitzl, Elisabeth Haschke-Becher, Tjalf Ziemssen, Johann Sellner
Repeated iv anti-CD20 treatment in multiple sclerosis: Long-term effects on peripheral immune cell subsets. Annals of clinical and translational neurology 11 (2) (2024)
Ferdinand Otto, Michael Seiberl, Bieler Lara, Tobias Moser, Waltraud Kleindienst, Wallner-Essl Walter, Koelblinger Peter, Peter Wipfler, Andrea Harrer
Beyond T cell toxicity-Intrathecal chemokine C-X-C motif ligand indicating B cell involvement in immune-related adverse events following checkpoint inhibition: A two-case series and literature review. European journal of neurology (2024)
Julia Feige, Tobias Moser, Katja Akgün, Kerstin Schwenker, Wolfgang Hitzl, Elisabeth Haschke-Becher, Tjalf Ziemssen, Johann Sellner
Repeated iv anti-CD20 treatment in multiple sclerosis: Long-term effects on peripheral immune cell subsets. Annals of clinical and translational neurology (2024)
Ferdinand Otto, Michael Seiberl, Lara Bieler, Tobias Moser, Waltraud Kleindienst, Walter Wallner-Essl, Peter Koelblinger, Peter Wipfler, Andrea Harrer
Beyond T cell toxicity - Intrathecal chemokine CXCL13 indicating B cell involvement in immune-related adverse events following checkpoint inhibition: A two-case series and literature review. European journal of neurology 31 (7) (2024)
Tobias Moser, Fabian Foettinger, Wolfgang Hitzl, Bianka Novotna, Thomas Berger, Gabriel Bsteh, Franziska Di Pauli, Harald Hegen, Barbara Kornek, Dieter Langenscheidt, Johann Sellner
Alemtuzumab treatment for multiple sclerosis in Austria: An observational long-term outcome study. Annals of clinical and translational neurology 11 (6) (2024)
Julia Feige, Tobias Moser, Katja Akgün, Kerstin Schwenker, Wolfgang Hitzl, Elisabeth Haschke-Becher, Tjalf Ziemssen, Johann Sellner
Repeated iv anti-CD20 treatment in multiple sclerosis: Long-term effects on peripheral immune cell subsets. Annals of clinical and translational neurology 11 (2) (2024)
Julia Feige, Tobias Moser, Katja Akgün, Kerstin Schwenker, Wolfgang Hitzl, Elisabeth Haschke-Becher, Tjalf Ziemssen, Johann Sellner
Repeated iv anti-CD20 treatment in multiple sclerosis: Long-term effects on peripheral immune cell subsets. Annals of clinical and translational neurology 11 (2) (2024)
Tobias Moser, Fabian Foettinger, Wolfgang Hitzl, Bianka Novotna, Thomas Berger, Gabriel Bsteh, Franziska Di Pauli, Harald Hegen, Barbara Kornek, Dieter Langenscheidt, Johann Sellner
Alemtuzumab treatment for multiple sclerosis in Austria: An observational long-term outcome study. Annals of clinical and translational neurology 11 (6) (2024)
Julia Feige, Tobias Moser, Katja Akgün, Kerstin Schwenker, Wolfgang Hitzl, Elisabeth Haschke-Becher, Tjalf Ziemssen, Johann Sellner
Repeated iv anti-CD20 treatment in multiple sclerosis: Long-term effects on peripheral immune cell subsets. Annals of clinical and translational neurology 11 (2) (2024)
Tobias Moser, Eugen Trinka
Epilepsy surgery in multiple sclerosis. Epileptic disorders : international epilepsy journal with videotape (2024)
Tobias Moser, Fabian Foettinger, Wolfgang Hitzl, Bianka Novotna, Thomas Berger, Gabriel Bsteh, Franziska Di Pauli, Harald Hegen, Barbara Kornek, Dieter Langenscheidt, Johann Sellner
Alemtuzumab treatment for multiple sclerosis in Austria: An observational long-term outcome study. Annals of clinical and translational neurology (2024)
Tobias Moser, Eugen Trinka
Epilepsy surgery in multiple sclerosis. Epileptic disorders : international epilepsy journal with videotape 26 (2) (2024)
Ferdinand Otto, Michael Seiberl, Lara Bieler, Tobias Moser, Waltraud Kleindienst, Walter Wallner-Essl, Peter Koelblinger, Peter Wipfler, Andrea Harrer
Beyond T cell toxicity - Intrathecal chemokine CXCL13 indicating B cell involvement in immune-related adverse events following checkpoint inhibition: A two-case series and literature review. European journal of neurology 31 (7) (2024)
Tobias Moser, Fabian Foettinger, Wolfgang Hitzl, Bianka Novotna, Thomas Berger, Gabriel Bsteh, Franziska Di Pauli, Harald Hegen, Barbara Kornek, Dieter Langenscheidt, Johann Sellner
Alemtuzumab treatment for multiple sclerosis in Austria: An observational long-term outcome study. Annals of clinical and translational neurology 11 (6) (2024)
Fabian Foettinger, Georg Pilz, Peter Wipfler, Andrea Harrer, Jan Marco Kern, Eugen Trinka, Tobias Moser
Immunomodulatory Aspects of Therapeutic Plasma Exchange in Neurological Disorders-A Pilot Study. International journal of molecular sciences 24 (7) (2023)
Michael Seiberl, Julia Feige, Patrick Hilpold, Wolfgang Hitzl, Lukas Machegger, Arabella Buchmann, Micheal Khalil, Eugen Trinka, Andrea Harrer, Peter Wipfler, Tobias Moser
Serum Neurofilament Light Chain as Biomarker for Cladribine-Treated Multiple Sclerosis Patients in a Real-World Setting. International journal of molecular sciences 24 (4) (2023)
Michael Seiberl, Julia Feige, Patrick Hilpold, Wolfgang Hitzl, Lukas Machegger, Arabella Buchmann, Micheal Khalil, Eugen Trinka, Andrea Harrer, Peter Wipfler, Tobias Moser
Serum Neurofilament Light Chain as Biomarker for Cladribine-Treated Multiple Sclerosis Patients in a Real-World Setting. International journal of molecular sciences 24 (4) (2023)
Anna-Maria Wiesinger, Brian W Bigger, Roberto Giugliani, Christina Lampe, Maurizio Scarpa, Tobias Moser, Christoph Kampmann, Georg Zimmermann, Florian B Lagler
RETRACTED: Wiesinger et al. An Innovative Tool for Evidence-Based, Personalized Treatment Trials in Mucopolysaccharidosis. Pharmaceutics 2023, 15 , 1565. Pharmaceutics 15 (11) (2023)
Anna-Maria Wiesinger, Brian W Bigger, Roberto Giugliani, Christina Lampe, Maurizio Scarpa, Tobias Moser, Christoph Kampmann, Georg Zimmermann, Florian B Lagler
An Innovative Tool for Evidence-Based, Personalized Treatment Trials in Mucopolysaccharidosis. Pharmaceutics 15 (5) (2023)
Michael Seiberl, Julia Feige, Patrick Hilpold, Wolfgang Hitzl, Lukas Machegger, Arabella Buchmann, Micheal Khalil, Eugen Trinka, Andrea Harrer, Peter Wipfler, Tobias Moser
Serum Neurofilament Light Chain as Biomarker for Cladribine-Treated Multiple Sclerosis Patients in a Real-World Setting. International journal of molecular sciences 24 (4) (2023)
Michael Seiberl, Julia Feige, Patrick Hilpold, Wolfgang Hitzl, Lukas Machegger, Arabella Buchmann, Micheal Khalil, Eugen Trinka, Andrea Harrer, Peter Wipfler, Tobias Moser
Serum Neurofilament Light Chain as Biomarker for Cladribine-Treated Multiple Sclerosis Patients in a Real-World Setting. International journal of molecular sciences 24 (4) (2023)
Julia Feige, Klaus Berek, Michael Seiberl, Patrick Hilpold, Wolfgang Hitzl, Franziska Di Pauli, Harald Hegen, Florian Deisenhammer, Eugen Trinka, Andrea Harrer, Peter Wipfler, Tobias Moser
Humoral Response to SARS-CoV-2 Antigen in Patients Treated with Monoclonal Anti-CD20 Antibodies: It Is Not All about B Cell Recovery. Neurology international 14 (4) (2022)
Tobias Moser, Ciara O'Sullivan, Ferdinand Otto, Wolfgang Hitzl, Georg Pilz, Kerstin Schwenker, Cornelia Mrazek, Elisabeth Haschke-Becher, Eugen Trinka, Peter Wipfler, Andrea Harrer
Long-term immunological consequences of anti-CD20 therapies on humoral responses to COVID-19 vaccines in multiple sclerosis: an observational study. Therapeutic advances in neurological disorders 15 (2022)
Christine Harrer, Ferdinand Otto, Richard Friedrich Radlberger, Tobias Moser, Georg Pilz, Peter Wipfler, Andrea Harrer
The CXCL13/CXCR5 Immune Axis in Health and Disease-Implications for Intrathecal B Cell Activities in Neuroinflammation. Cells 11 (17) (2022)
Tobias Moser, Ciara O'Sullivan, Christian Puttinger, Julia Feige, Georg Pilz, Elisabeth Haschke-Becher, Janne Cadamuro, Hannes Oberkofler, Wolfgang Hitzl, Andrea Harrer, Jörg Kraus, Eugen Trinka, Peter Wipfler
Pre-Existing Humoral Immunological Memory Is Retained in Patients with Multiple Sclerosis Receiving Cladribine Therapy. Biomedicines 9 (11) (2021)
Tobias Moser, Lena Hoepner, Kerstin Schwenker, Michael Seiberl, Julia Feige, Katja Akgün, Elisabeth Haschke-Becher, Tjalf Ziemssen, Johann Sellner
Cladribine Alters Immune Cell Surface Molecules for Adhesion and Costimulation: Further Insights to the Mode of Action in Multiple Sclerosis. Cells 10 (11) (2021)
Julia Feige, Tobias Moser, Lara Bieler, Kerstin Schwenker, Larissa Hauer, Johann Sellner
Vitamin D Supplementation in Multiple Sclerosis: A Critical Analysis of Potentials and Threats. Nutrients 12 (3) (2020)
Julia Feige, Tobias Moser, Larissa Hauer, Slaven Pikija, Johann Sellner
Clinical Challenges in a 49-Year-Old Patient with Severe Tick-Borne Myeloradiculitis Despite Complete Active Vaccination. Vaccines 8 (1) (2020)